HARROW HEALTH INC's ticker is HROW and the CUSIP is 415858109. A total of 129 filers reported holding HARROW HEALTH INC in Q3 2023. The put-call ratio across all filers is 5.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,896,145 | -11.0% | 688,667 | +17.9% | 0.00% | 0.0% |
Q2 2023 | $11,116,942 | +436.0% | 583,873 | +495.7% | 0.00% | – |
Q1 2023 | $2,073,955 | -19.1% | 98,013 | -43.5% | 0.00% | – |
Q4 2022 | $2,562,720 | +144.5% | 173,626 | +100.0% | 0.00% | – |
Q3 2022 | $1,048,000 | +65.8% | 86,813 | 0.0% | 0.00% | – |
Q2 2022 | $632,000 | +6.8% | 86,813 | 0.0% | 0.00% | – |
Q1 2022 | $592,000 | -16.7% | 86,813 | +5.5% | 0.00% | – |
Q4 2021 | $711,000 | -4.9% | 82,292 | 0.0% | 0.00% | – |
Q3 2021 | $748,000 | +15.4% | 82,292 | +17.9% | 0.00% | – |
Q2 2021 | $648,000 | -72.4% | 69,792 | -80.0% | 0.00% | – |
Q1 2021 | $2,352,000 | -1.6% | 348,423 | -0.0% | 0.00% | – |
Q4 2020 | $2,391,000 | +62.3% | 348,567 | +32.3% | 0.00% | – |
Q3 2020 | $1,473,000 | +10.8% | 263,566 | +3.3% | 0.00% | – |
Q2 2020 | $1,329,000 | +421.2% | 255,163 | +677.0% | 0.00% | – |
Q4 2019 | $255,000 | +71.1% | 32,838 | +23.9% | 0.00% | – |
Q3 2019 | $149,000 | -7.5% | 26,500 | +43.1% | 0.00% | – |
Q2 2019 | $161,000 | – | 18,513 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 3,140,000 | $29,171,000 | 4.84% |
Ophir Asset Management Pty Ltd | 1,670,817 | $15,522,000 | 2.73% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 378,389 | $3,515,000 | 1.16% |
Birchview Capital, LP | 180,000 | $1,672,000 | 1.00% |
Diametric Capital, LP | 82,443 | $766,000 | 0.55% |
Precision Wealth Strategies, LLC | 65,530 | $609,000 | 0.52% |
Uniplan Investment Counsel, Inc. | 507,602 | $4,715,000 | 0.28% |
BARD ASSOCIATES INC | 86,315 | $802,000 | 0.26% |
EAM Investors, LLC | 142,272 | $1,322,000 | 0.20% |
Zebra Capital Management LLC | 15,786 | $147,000 | 0.17% |